stavros g vizirgianakis  trumbull ct  intelius sign in we found stavros g vizirgianakis in trumbull ct stavros g vizirgianakis intelius found that stavros g vizirgianakis is a male between  and  years old from trumbull ct we have connected them to  addresses  phones and  relatives or associates get report now age stavros g vizirgianakis is in his s stavros has lived in trumbull ct farmingdale ny mountain view ca stavros g vizirgianakis gendermale professional status board member at misonix  inc get report now want to know more about stavros get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about stavros or use our people search engine to find others get background check on stavros g vizirgianakis get a criminal check on stavros g vizirgianakis get a public record report on stavros g vizirgianakis get a people search report on stavros g vizirgianakis stavros g vizirgianakiss contact information known cities lived in find out where stavros g vizirgianakis has lived as well as stavros g vizirgianakiss phone numbers and email addresses stavros g vizirgianakis has lived in  states connecticut address for stavros g vizirgianakis  h d trumbull ct has lived in trumbull ct farmingdale ny get full address report phone numbers associated with stavros g vizirgianakis    trumbull ct    mountain view ca    washington dc get full phone report email addresses associated with stavros g vizirgianakis get email report stavros g vizirgianakiss education information known schools attended learn about stavros g vizirgianakiss academic history find out which schools stavros g vizirgianakis attended the dates attended as well as the degrees stavros g vizirgianakis received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act stavros g vizirgianakis has attended  school university of south africa stavros g vizirgianakis has a degree in commerce stavros g vizirgianakiss professional information information regarding stavros g vizirgianakiss professional history find out previous places stavros g vizirgianakis has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act stavros g vizirgianakis has worked at  places company misonix  inc title board member company surgical innovations group plc title founder stavros g vizirgianakiss experience title board member company misonix  inc job details misonix inc designs develops manufactures and markets therapeutic ultrasonic medical devices misonixs therapeutic ultrasonic platform is the basis for several innovative medical technologies addressing a combined market estimated to be in excess of  billion annually misonixs proprietary ultrasonic medical devices are used in spine surgery neurosurgery orthopedic surgery wound debridement cosmetic surgery laparoscopic surgery and other surgical and medical applications title founder company surgical innovations group plc job details surgical innovations group plc is a listed medical technology company with an impressive international clinical footprint the group based in leeds develops proprietary blue sky surgical products to address the unmet clinical needs for minimally invasive surgery â€œmisâ€� surgical innovationâ€™s pioneering laparoscopic products have been manufactured around its innovative resposable technology a concept designed to reduce the mounting costs of healthcare whilst not compromising on procedural quality its portfolio of products currently include yelloportplus a port access system the logirange of reusable instruments and pretzelflex the worldâ€™s first reusable pretzelshaped organ and tissue retractor all of surgical innovationâ€™s branded products have proven success in reducing procedural costs by up to twothirds and improved clinical performance for both the surgeon and patients additional professional information on stavros g vizirgianakis see stavros g vizirgianakiss linkedin profile stavros g vizirgianakiss social network and potential email matches find out potential social network profiles and potential email usernamed for stavros g vizirgianakis stavros g vizirgianakiss known social networks and potential email matches find all of stavros g vizirgianakiss social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches stavros vizirgianakis username matches stavrosvizirgianakis vizirgianakisstavros stavrosvizirgianakis vizirgianakisstavros stavrosvizirgianakis vizirgianakisstavros stavrosvizirgianakis vizirgianakisstavros svizirgianakis popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches s vizirgianakis intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft stavros g vizirgianakis  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in stavros g vizirgianakis president chief executive officer and director at misonix inc view full profile are you stavros g vizirgianakis claim your profile   sign up for equilar atlas and view stavros g vizirgianakiss full profile with equilar atlas you can identify corporate executives in stavros g vizirgianakiss network and community follow changes in stavros g vizirgianakiss employment and moneyinmotion connect with stavros g vizirgianakis through your network of contacts stavros g vizirgianakiss executive work history current president chief executive officer and director misonix inc past to view stavros g vizirgianakiss complete executive work history sign up now age      stavros g vizirgianakiss biography stavros g vizirgianakis became the companys interim chief executive officer in september  and its fulltime chief executive officer in december  mr vizirgianakis has a distinguished career in the medical devices field having worked for united states surgical corporation as director of sales for subsaharan africa and later tyco healthcare in the capacity of general manager south africa in  mr vizirgianakis cofounded surgical innovations which has become one of the largest privately owned medical device distributors in the african region and now part of the johannesburg stock exchange listed entity ascendis health in tha  read more stavros g vizirgianakis became the companys interim chief executive officer in september  and its fulltime chief executive officer in december  mr vizirgianakis has a distinguished career in the medical devices field having worked for united states surgical corporation as director of sales for subsaharan africa and later tyco healthcare in the capacity of general manager south africa in  mr vizirgianakis cofounded surgical innovations which has become one of the largest privately owned medical device distributors in the african region and now part of the johannesburg stock exchange listed entity ascendis health in that capacity mr vizirgianakis acted as a distributor of the companys products mr vizirgianakis was managing director of ascendis medical from january  through july  mr vizirgianakis also served on the board of tenaxis medical and is a strategic investor and advisor to numerous medical device startups and established companies in this field mr vizirgianakis has a degree in commerce from the university of south africa the board believes mr vizirgianakis industry knowledge sales and marketing experience and his vast international business relationships qualify him to serve as a director source misonix inc on    sign up for equilar atlas and view stavros g vizirgianakiss full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like stavros g vizirgianakis more specifically youll be able to identify corporate executives in stavros g vizirgianakiss network and community follow changes in stavros g vizirgianakiss employment and moneyinmotion connect with stavros g vizirgianakis through your network of conections view full profile   search for over  executive profiles bio example stavros g vizirgianakis stavros g vizirgianakiss connections  sign up now to view stavros g vizirgianakiss  connections » thomas f oneill board member bankfinancial robert s ludecker senior vice president global sales and marketing misonix inc frank napoli former vice president  operations misonix inc richard a zaremba senior vice president finance secretary and treasurer misonix inc john w gildea board member misonix inc thomas m patton dir president and chief executive officer cas medical systems inc christopher h wright vice president domestic sales misonix inc michael a mcmanus chairman president and chief executive officer misonix inc charles miner board member misonix inc daniel voic vice president research and development and engineering misonix inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   stavros g vizirgianakis appointed president and ceo of misonix inc  marketwatch bulletin investor alert press release dec    am est stavros g vizirgianakis appointed president and ceo of misonix inc mr vizirgianakis has served as interim ceo since september  farmingdale ny dec   prnewswire   misonix inc quoteszigmancomposite mson   a leading provider of ultrasonic surgical tools announced today the appointment of stavros g vizirgianakis as the companys president and chief executive officer effective immediately mr vizirgianakis has served as interim chief executive officer since september   and has served as a member of the misonix board of directors since may  separately the company announced the resignation of t guy minetti from the board of directors after leading the board process to recruit mr vizirgianakis to accept the ceo role since being appointed interim ceo stavros has quickly engaged in the business with an intense focus on driving misonixs recurring revenue business model said mr minetti as the board considered the evolving needs of the company we determined that this focus as well as stavros broad international healthcare experience made him the right person to lead misonix  after more than a dozen years of service to the company i am confident that the leadership is in place to take misonix to new heights and i wish the company well mr vizirgianakis has a distinguished career in the medical devices field having worked for united states surgical corporation as director of sales for subsaharan africa and later tyco healthcare in the capacity of general manager south africa mr vizirgianakis was managing director of ascendis medical from january  to july   in  mr vizirgianakis cofounded surgical innovations which has become one of the largest privately owned medical device distributors in the african region and now part of the johannesburg stock exchange listed entity ascendis health in that capacity mr vizirgianakis acted as an independent distributor of the misonix line of products  mr vizirgianakis also served on the board of tenaxis medical and is a strategic investor and advisor to numerous medical device startups and established companies in this field mr vizirgianakis has a degree in commerce from the university of south africa with the support of the board and our talented team of employees we are confident that stavros will apply his skill set and experience to driving growth and building shareholder value for misonix said thomas patton lead director of the company and we are grateful for mr minettis long term of service to the company we will miss his counsel and we wish him well mr vizirgianakis commented i look forward with great enthusiasm to expanding our markets both within the united states and internationally while our ultrasonic technologies and tools are generally associated with delicate spine surgery and the debridement of diabetic and burn wounds i firmly believe there are other surgical procedures that can benefit from the mitigation of soft tissue collateral damage minimizing blood loss and the generation of better patient outcomes we have leadingedge technology and products highly talented people and the dedication to become leaders in the markets in which we compete i am excited with the opportunities ahead on october   misonix announced that mr vizirgianakis invested  million through the purchase from the company of  shares of misonix common stock in a private placement at a price of  per share upon closing of the acquisition of these shares mr vizirgianakis became the companys largest shareholder about misonix misonix inc designs develops manufactures and markets therapeutic ultrasonic medical devices misonixs therapeutic ultrasonic platform is the basis for several innovative medical technologies addressing a combined market estimated in excess of  billion annually misonixs proprietary ultrasonic medical devices are used in spine surgery neurosurgery orthopedic surgery wound debridement cosmetic surgery laparoscopic surgery and other surgical and medical applications additional information is available on the companys website at wwwmisonixcom safe harbor statement with the exception of historical information contained in this press release content herein may contain forward looking statements that are made pursuant to the safe harbor provisions of the private securities litigation reform act of  these statements are based on managements current expectations and are subject to uncertainty and changes in circumstances investors are cautioned that forwardlooking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made these factors include general economic conditions delays and risks associated with the performance of contracts risks associated with international sales and currency fluctuations uncertainties as a result of research and development acceptable results from clinical studies including publication of results and patientprocedure data with varying levels of statistical relevancy risks involved in introducing and marketing new products potential acquisitions consumer and industry acceptance litigation andor court proceedings including the timing and monetary requirements of such activities the timing of finding strategic partners and implementing such relationships regulatory risks including approval of pending andor contemplated k filings the ability to achieve and maintain profitability in the companys business lines the completion of the investigation related to identified deficiencies in internal control over financial reporting and other factors discussed in the companys annual report on form k subsequent quarterly reports on form q and current reports on form k the company disclaims any obligation to update its forwardlooking relationships corporate contact         investor contact joe dwyer                        joe diaz misonix inc                     lytham partners                       investmisonixcon           infomisonixcom   to view the original version on pr newswire visit httpwwwprnewswirecomnewsreleasesstavrosgvizirgianakisappointedpresidentandceoofmisonixinchtml source misonix inc copyright c  pr newswire all rights reserved quoteszigmancomposite add to watchlist mson misonix inc us  us nasdaq     volume  july   p pe rationa dividend yieldna market cap million rev per employee most popular  market extra wall street isn’t ready for a point tumble in the dow industrials  all the companies in jeff bezos’s empire in one large chart  market snapshot sp  nasdaq finish lower after amazon disappointment dow closes at record  marketwatch first take intel earnings have message for amd and nvidia ‘bring it on’  sectorwatch silicon valleys corporatecampus building boom is a cautionary tale find a broker partner center » featured stories seeing america again through new eyes how to dig yourself out of debt move over tesla karma unveils its hybrid sports car the salary you need to afford a home in these  cities why opec will never cut production again log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  unavailable  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries this feature is temporarily unavailable copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top msfg log in for events vcyt boot tbbk logm jack log in for events rev gifi rdwr impv find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  am et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  firstword medtech login  subscribe saturday july   get unlimited medtech plus subscriptions for one low fixed rate with a firstword medtech country licenseclick here for more details home my newsall my news my companywatch my conditionwatch my marketsegmentwatch my medicalmeetingwatch my productwatch my regulatorywatch all newsexplore latest news all company news all condition news all medical meeting news all product news all market segment news all regulatory market and agency news all therapeutic category news most popularmost popular in the last  hours most popular in the last  days most popular in the last  days storywatchduodenoscope reprocessing in focus emerging markets latest earnings reports pharma alliances product approvals and certifications us vaginalmesh product lawsuits where health meets tech servicesmobile search twitter rss podcasts radio you have reached your maximum article count for the day select your firstword medtech service firstword medtech where people who know first go firstsubscribe to firstword medtech for an overview of top medical technology industry news stories from across the globe in a format that is quick and easy to use firstword medtech plus your news your way subscribe to firstword medtech plus for more indepth medtech news and intelligence with the convenience of user customisation   firstword medtech services available firstword medtech plus services available breaking news yesyes  customisable to your specific preferences top stories yesyes daily email newsletter yesyes  choice of  editions mobile device compatible yesyes podcasts yesyes radio yesyes global coverage yesyes company news restricted accessunlimited access plus monitor up to  different companies of your choice in my companywatch condition news restricted accessunlimited access plus monitor up to  different medical conditions of your choice in my conditionwatch product news restricted accessunlimited access plus monitor up to  different compoundsproducts of your choice in my productwatch regulatory market and agency news restricted accessunlimited access plus monitor up to  markets and related regulatory bodies of your choice in my regulatorywatch medical meeting news restricted accessunlimited access to the medtech conferences listed plus monitor up to  meetings of your choice in mymedical meetingwatch therapeutic category news restricted accessfull access the most popular news items restricted accessfull access story watch restricted accessfull access archive and news search not availablefull access annual subscription freeus  riskfree guarantee we are confident that you will see the benefits of upgrading to firstword medtech plus however if for any reason you are not satisfied with your subscription you may cancel it within  days and receive a full refundif for any reason you are not satisfied with your subscription you may cancel it within  days for a full refundplease feel free to contact us for more information about firstword medtech  refer a colleague  upgrade your firstword medtech  contact firstword medtech  firstword reportsadvertise with firstword medtech  industry partner showcaseall contents copyright   doctors guide publishing limited all rights reservedterms of use  privacy policy mson stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsmson misonix inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade price history download to csv file download to excel file log in for more news expand all collapse all briefmisonix reports q loss per share  reuters –  pm et  misonix inc mson  misonix mson reports third quarter fiscal year  financial results  q loss per share   q sales rose  percent to  million  misonix inc mson at march   company maintained cash and cash equivalents of  million with no longterm debt source text for eikon further company coverage misonix reports third quarter fiscal year  financial results globenewswire –  pm et  misonix inc mson a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes announced today financial results for the three and nine months ended march   misonix inc to report third quarter fiscal year  financial results on tuesday may   globenewswire –  pm et  misonix inc mson a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes announced today that it will report financial results for the third quarter of fiscal year  on tuesday may   page page  todays and upcoming events aug  mson to announce q earnings after market unconfirmed past events last  days jun  shareholders meeting data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe stavros g vizirgianakis appointed president and ceo of misonix employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       stavros g vizirgianakis appointed president and ceo of misonix mson tweet   am   life sciences jobs     bullet newest jobs  last  hours   bullet california jobs   bullet massachusetts jobs   bullet new jersey jobs   bullet maryland jobs   bullet washington jobs   view more jobs stavros g vizirgianakis appointed president and ceo of misonix farmingdale ny dec   prnewswire  misonix inc nasdaq mson a leading provider of ultrasonic surgical tools announced today the appointment of stavros g vizirgianakis as the companys president and chief executive officer effective immediately mr vizirgianakis has served as interim chief executive officer since september   and has served as a member of the misonix board of directors since may  separately the company announced the resignation of t guy minetti from the board of directors after leading the board process to recruit mr vizirgianakis to accept the ceo role since being appointed interim ceo stavros has quickly engaged in the business with an intense focus on driving misonixs recurring revenue business model said mr minetti as the board considered the evolving needs of the company we determined that this focus as well as stavros broad international healthcare experience made him the right person to lead misonix  after more than a dozen years of service to the company i am confident that the leadership is in place to take misonix to new heights and i wish the company wellmr vizirgianakis has a distinguished career in the medical devices field having worked for united states surgical corporation as director of sales for subsaharan africa and later tyco healthcare in the capacity of general manager south africa mr vizirgianakis was managing director of ascendis medical from january  to july   in  mr vizirgianakis cofounded surgical innovations which has become one of the largest privately owned medical device distributors in the african region and now part of the johannesburg stock exchange listed entity ascendis health in that capacity mr vizirgianakis acted as an independent distributor of the misonix line of products  mr vizirgianakis also served on the board of tenaxis medical and is a strategic investor and advisor to numerous medical device startups and established companies in this field mr vizirgianakis has a degree in commerce from the university of south africawith the support of the board and our talented team of employees we are confident that stavros will apply his skill set and experience to driving growth and building shareholder value for misonix said thomas patton lead director of the company and we are grateful for mr minettis long term of service to the company we will miss his counsel and we wish him wellmr vizirgianakis commented i look forward with great enthusiasm to expanding our markets both within the united states and internationally while our ultrasonic technologies and tools are generally associated with delicate spine surgery and the debridement of diabetic and burn wounds i firmly believe there are other surgical procedures that can benefit from the mitigation of soft tissue collateral damage minimizing blood loss and the generation of better patient outcomes we have leadingedge technology and products highly talented people and the dedication to become leaders in the markets in which we compete i am excited with the opportunities ahead on october   misonix announced that mr vizirgianakis invested  million through the purchase from the company of  shares of misonix common stock in a private placement at a price of  per share upon closing of the acquisition of these shares mr vizirgianakis became the companys largest shareholderabout misonixmisonix inc designs develops manufactures and markets therapeutic ultrasonic medical devices misonixs therapeutic ultrasonic platform is the basis for several innovative medical technologies addressing a combined market estimated in excess of  billion annually misonixs proprietary ultrasonic medical devices are used in spine surgery neurosurgery orthopedic surgery wound debridement cosmetic surgery laparoscopic surgery and other surgical and medical applications additional information is available on the companys website at wwwmisonixcomsafe harbor statementwith the exception of historical information contained in this press release content herein may contain forward looking statements that are made pursuant to the safe harbor provisions of the private securities litigation reform act of  these statements are based on managements current expectations and are subject to uncertainty and changes in circumstances investors are cautioned that forwardlooking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made these factors include general economic conditions delays and risks associated with the performance of contracts risks associated with international sales and currency fluctuations uncertainties as a result of research and development acceptable results from clinical studies including publication of results and patientprocedure data with varying levels of statistical relevancy risks involved in introducing and marketing new products potential acquisitions consumer and industry acceptance litigation andor court proceedings including the timing and monetary requirements of such activities the timing of finding strategic partners and implementing such relationships regulatory risks including approval of pending andor contemplated k filings the ability to achieve and maintain profitability in the companys business lines the completion of the investigation related to identified deficiencies in internal control over financial reporting and other factors discussed in the companys annual report on form k subsequent quarterly reports on form q and current reports on form k the company disclaims any obligation to update its forwardlooking relationshipscorporate contact        investor contactjoe dwyer                       joe diazmisonix inc                    lytham partners                    investmisonixcon          infomisonixcom to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesstavrosgvizirgianakisappointedpresidentandceoofmisonixinchtmlsource misonix inc read at reuters read at street insider read at biospacecom related news stavros vizirgianakis interim misonix mson ceo invests  million in misonix common stock fdas woodcock speaks about one of the agencys most controversial decisions misonix msons interim ceo invests  million into company after ceo ouster interim alexion alxn boss says we need to move on misonix mson reports nasdaqs acceptance of its plan to regain listing compliance obamas science adviser explains why a sciencesavvy president matters misonix mson reports receipt of deficiency letter from the nasdaq stock market the  best biopharma ceos of  are misonix mson files for extension of time for quarterly report on form q fibrocell fcsc appoints new chief executive officer please enable javascript to view the comments powered by disqus comments powered by disqus • reuters • street insider • biospacecom • misonix incorporated   • biotechpharma  personnel • medical devices • medical dev  diag  personnel                 misonix president and chief executive officer to retire misonix president and chief executive officer to retire news provided by misonix inc aug    et share this article farmingdale ny aug   prnewswire  misonix inc nasdaq mson an international surgical device company that designs manufactures and markets innovative therapeutic ultrasonic products for spine surgery neurosurgery wound debridement skull based surgery laparoscopic surgery and other surgical applications announced that effective september   michael a mcmanus jr is resigning as a director and chairman of the board of directors of misonix and retiring as the companys president and chief executive officer effective september   stavros g vizirgianakis a member of the misonix board of directors will serve on an unpaid basis as misonixs interim chief executive officer misonix and mr vizirgianakis are in negotiations for him to accept employment as misonixs fulltime chief executive officer mr vizirgianakis has served on the misonix board since may  he holds a  ownership stake in misonix he has been involved with misonix as early as september  as the owner of a company acting as misonixs south african distributor mr vizirgianakis said i am honored to be asked to serve as interim chief executive officer and am excited about the companys products and future  the misonix team will no doubt continue to put forth their best efforts to design develop and manufacture cuttingedge technology for the medical device field mr mcmanus commented after  years as ceo i retire with gratitude for the dedicated professionals who have contributed to the companys innovation and growth and with great confidence in the companys future potential and the leadership of stavros vizirgianakis i look forward to doing whatever i can to be helpful to him as he transitions to his new role about misonixmisonix inc designs develops manufactures and markets therapeutic ultrasonic medical devices misonixs therapeutic ultrasonic platform is the basis for several innovative medical technologies addressing a combined market estimated to be in excess of  billion annually misonixs proprietary ultrasonic medical devices are used in spine surgery neurosurgery orthopedic surgery wound debridement cosmetic surgery laparoscopic surgery and other surgical and medical applications  additional information is available on the companys web site at wwwmisonixcom safe harbor statementwith the exception of historical information contained in this press release content herein may contain forward looking statements that are made pursuant to the safe harbor provisions of the private securities litigation reform act of  these statements are based on managements current expectations and are subject to uncertainty and changes in circumstances investors are cautioned that forwardlooking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made these factors include general economic conditions delays and risks associated with the performance of contracts risks associated with international sales and currency fluctuations uncertainties as a result of research and development acceptable results from clinical studies including publication of results and patientprocedure data with varying levels of statistical relevancy risks involved in introducing and marketing new products potential acquisitions consumer and industry acceptance litigation andor court proceedings including the timing and monetary requirements of such activities the timing of finding strategic partners and implementing such relationships regulatory risks including approval of pending andor contemplated k filings the ability to achieve and maintain profitability in the companys business lines and other factors discussed in the companys annual report on form k subsequent quarterly reports on form q and current reports on form k the company disclaims any obligation to update its forwardlooking relationships corporate contact  investor contact misonix contact  joe diaz richard zaremba  lytham partners        investmisonixcom  infomisonixcom logo  httpphotosprnewswirecomprnhlogo   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesmisonixpresidentandchiefexecutiveofficertoretirehtml source misonix inc related links httpwwwmisonixcom sep    et preview misonix files for extension of time for annual report on form k appoints interim cfo aug    et preview bonescalpel® handson workshop draws  surgeons at the  scoliosis research society worldwide conference in bali indonesia my news release contains wide tables view fullscreen also from this source mar    et misonix inc to review financial results for first half of mar    et misonix files forms q for first and second quarters of fiscal explore more news releases in similar topics health care  hospitals medical equipment personnel announcements you just read misonix president and chief executive officer to retire news provided by misonix inc aug    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search stavros g vizirgianakis appointed president and ceo of misonix inc stavros g vizirgianakis appointed president and ceo of misonix inc mr vizirgianakis has served as interim ceo since september  news provided by misonix inc dec    et share this article farmingdale ny dec   prnewswire  misonix inc nasdaq mson a leading provider of ultrasonic surgical tools announced today the appointment of stavros g vizirgianakis as the companys president and chief executive officer effective immediately mr vizirgianakis has served as interim chief executive officer since september   and has served as a member of the misonix board of directors since may  separately the company announced the resignation of t guy minetti from the board of directors after leading the board process to recruit mr vizirgianakis to accept the ceo role since being appointed interim ceo stavros has quickly engaged in the business with an intense focus on driving misonixs recurring revenue business model said mr minetti as the board considered the evolving needs of the company we determined that this focus as well as stavros broad international healthcare experience made him the right person to lead misonix  after more than a dozen years of service to the company i am confident that the leadership is in place to take misonix to new heights and i wish the company well mr vizirgianakis has a distinguished career in the medical devices field having worked for united states surgical corporation as director of sales for subsaharan africa and later tyco healthcare in the capacity of general manager south africa mr vizirgianakis was managing director of ascendis medical from january  to july   in  mr vizirgianakis cofounded surgical innovations which has become one of the largest privately owned medical device distributors in the african region and now part of the johannesburg stock exchange listed entity ascendis health in that capacity mr vizirgianakis acted as an independent distributor of the misonix line of products  mr vizirgianakis also served on the board of tenaxis medical and is a strategic investor and advisor to numerous medical device startups and established companies in this field mr vizirgianakis has a degree in commerce from the university of south africa with the support of the board and our talented team of employees we are confident that stavros will apply his skill set and experience to driving growth and building shareholder value for misonix said thomas patton lead director of the company and we are grateful for mr minettis long term of service to the company we will miss his counsel and we wish him well mr vizirgianakis commented i look forward with great enthusiasm to expanding our markets both within the united states and internationally while our ultrasonic technologies and tools are generally associated with delicate spine surgery and the debridement of diabetic and burn wounds i firmly believe there are other surgical procedures that can benefit from the mitigation of soft tissue collateral damage minimizing blood loss and the generation of better patient outcomes we have leadingedge technology and products highly talented people and the dedication to become leaders in the markets in which we compete i am excited with the opportunities ahead on october   misonix announced that mr vizirgianakis invested  million through the purchase from the company of  shares of misonix common stock in a private placement at a price of  per share upon closing of the acquisition of these shares mr vizirgianakis became the companys largest shareholder about misonix misonix inc designs develops manufactures and markets therapeutic ultrasonic medical devices misonixs therapeutic ultrasonic platform is the basis for several innovative medical technologies addressing a combined market estimated in excess of  billion annually misonixs proprietary ultrasonic medical devices are used in spine surgery neurosurgery orthopedic surgery wound debridement cosmetic surgery laparoscopic surgery and other surgical and medical applications additional information is available on the companys website at wwwmisonixcom safe harbor statement with the exception of historical information contained in this press release content herein may contain forward looking statements that are made pursuant to the safe harbor provisions of the private securities litigation reform act of  these statements are based on managements current expectations and are subject to uncertainty and changes in circumstances investors are cautioned that forwardlooking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made these factors include general economic conditions delays and risks associated with the performance of contracts risks associated with international sales and currency fluctuations uncertainties as a result of research and development acceptable results from clinical studies including publication of results and patientprocedure data with varying levels of statistical relevancy risks involved in introducing and marketing new products potential acquisitions consumer and industry acceptance litigation andor court proceedings including the timing and monetary requirements of such activities the timing of finding strategic partners and implementing such relationships regulatory risks including approval of pending andor contemplated k filings the ability to achieve and maintain profitability in the companys business lines the completion of the investigation related to identified deficiencies in internal control over financial reporting and other factors discussed in the companys annual report on form k subsequent quarterly reports on form q and current reports on form k the company disclaims any obligation to update its forwardlooking relationships corporate contact         investor contact joe dwyer                        joe diaz misonix inc                     lytham partners                       investmisonixcon           infomisonixcom   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesstavrosgvizirgianakisappointedpresidentandceoofmisonixinchtml source misonix inc related links httpwwwmisonixcom feb    et preview misonix files form k announcing fiscal  financial results nov    et preview misonix reports nasdaqs acceptance of its plan to regain listing compliance my news release contains wide tables view fullscreen also from this source mar    et misonix inc to review financial results for first half of mar    et misonix files forms q for first and second quarters of fiscal explore more news releases in similar topics health care  hospitals medical equipment medical pharmaceuticals personnel announcements you just read stavros g vizirgianakis appointed president and ceo of misonix inc news provided by misonix inc dec    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search stavros g vizirgianakis appointed president and ceo of misonix inchomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp  dow  nasdaq listenwho is the face of pro baseballyahoo finances dan roberts and myles udland debate the business of baseballstavros g vizirgianakis appointed president and ceo of misonix incpr newswiredecember  reblogsharetweetsharefarmingdale ny dec   prnewswire  misonix inc mson a leading provider of ultrasonic surgical tools announced today the appointment of stavros g vizirgianakis as the companys president and chief executive officer effective immediately mr vizirgianakis has served as interim chief executive officer since september   and has served as a member of the misonix board of directors since may  separately the company announced the resignation of t guy minetti from the board of directors after leading the board process to recruit mr vizirgianakis to accept the ceo rolesince being appointed interim ceo stavros has quickly engaged in the business with an intense focus on driving misonixs recurring revenue business model said mr minetti as the board considered the evolving needs of the company we determined that this focus as well as stavros broad international healthcare experience made him the right person to lead misonix  after more than a dozen years of service to the company i am confident that the leadership is in place to take misonix to new heights and i wish the company wellmr vizirgianakis has a distinguished career in the medical devices field having worked for united states surgical corporation as director of sales for subsaharan africa and later tyco healthcare in the capacity of general manager south africa mr vizirgianakis was managing director of ascendis medical from january  to july   in  mr vizirgianakis cofounded surgical innovations which has become one of the largest privately owned medical device distributors in the african region and now part of the johannesburg stock exchange listed entity ascendis health in that capacity mr vizirgianakis acted as an independent distributor of the misonix line of products  mr vizirgianakis also served on the board of tenaxis medical and is a strategic investor and advisor to numerous medical device startups and established companies in this field mr vizirgianakis has a degree in commerce from the university of south africawith the support of the board and our talented team of employees we are confident that stavros will apply his skill set and experience to driving growth and building shareholder value for misonix said thomas patton lead director of the company and we are grateful for mr minettis long term of service to the company we will miss his counsel and we wish him wellmr vizirgianakis commented i look forward with great enthusiasm to expanding our markets both within the united states and internationally while our ultrasonic technologies and tools are generally associated with delicate spine surgery and the debridement of diabetic and burn wounds i firmly believe there are other surgical procedures that can benefit from the mitigation of soft tissue collateral damage minimizing blood loss and the generation of better patient outcomes we have leadingedge technology and products highly talented people and the dedication to become leaders in the markets in which we compete i am excited with the opportunities aheadon october   misonix announced that mr vizirgianakis invested  million through the purchase from the company of  shares of misonix common stock in a private placement at a price of  per share upon closing of the acquisition of these shares mr vizirgianakis became the companys largest shareholderread moreabout misonixmisonix inc designs develops manufactures and markets therapeutic ultrasonic medical devices misonixs therapeutic ultrasonic platform is the basis for several innovative medical technologies addressing a combined market estimated in excess of  billion annually misonixs proprietary ultrasonic medical devices are used in spine surgery neurosurgery orthopedic surgery wound debridement cosmetic surgery laparoscopic surgery and other surgical and medical applications additional information is available on the companys website at wwwmisonixcomsafe harbor statementwith the exception of historical information contained in this press release content herein may contain forward looking statements that are made pursuant to the safe harbor provisions of the private securities litigation reform act of  these statements are based on managements current expectations and are subject to uncertainty and changes in circumstances investors are cautioned that forwardlooking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made these factors include general economic conditions delays and risks associated with the performance of contracts risks associated with international sales and currency fluctuations uncertainties as a result of research and development acceptable results from clinical studies including publication of results and patientprocedure data with varying levels of statistical relevancy risks involved in introducing and marketing new products potential acquisitions consumer and industry acceptance litigation andor court proceedings including the timing and monetary requirements of such activities the timing of finding strategic partners and implementing such relationships regulatory risks including approval of pending andor contemplated k filings the ability to achieve and maintain profitability in the companys business lines the completion of the investigation related to identified deficiencies in internal control over financial reporting and other factors discussed in the companys annual report on form k subsequent quarterly reports on form q and current reports on form k the company disclaims any obligation to update its forwardlooking relationships corporate contact         investor contact joe dwyer                        joe diaz misonix inc                     lytham partners                       investmisonixcon           infomisonixcom  to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesstavrosgvizirgianakisappointedpresidentandceoofmisonixinchtmlreblogsharetweetsharerecently viewedyour list is emptywhat to read nextmeg whitmans out will ge chief executive take over ubersiliconbeatthis will be in everyones household by banyan hillsponsoredatt executives to run combined company after time warner dealreuterswind projects in peril as indian states rethink purchasesbloombergamazon surpasses b mark bezos briefly becomes the world’s richest personinvestopediaengineer finds pattern makes millions in stocksmoney morningsponsoredslimy slugs inspire potentially lifesaving medical gluebbc newsthe two pizza rule is a secret to productive meetings that helped amazon ceo jeff bezos become one of the worlds richest menbusiness insiderhere are the us targets north korea most likely wants to nukebusiness insiderdiscover it  out of  avg by k customersdiscover cardsponsoredthe real reason overseas manufacturing is coming to americayahoo financechevron and exxon mobil have a tough path ahead nyse traderyahoo finance videostocks mixed after heavy earnings weekwhats the problem with joel osteenchurchleaderscomsponsoredjohn mccain heres why i voted no and killed the skinny repealbusiness insidertrump to cops please dont be too nice while arresting thugs and dont worry about their heads when you toss them in the paddy wagonbusiness insiderjohn mccain defends health care vote as the right thing to dotallgpa today trump will tweet that mccain is unfit to be in office and call him a coward for being a prisoner of war the  yr old is probably typing up the tweet as we speakjoin the conversation